Dr. Judy Chou is the CEO & President of AltruBio, Inc. Before taking on her current roles, she headed the global Biotech organization at Bayer Pharmaceuticals overseeing the development, manufacturing and distribution of Bayer’s biotechnology product portfolio & 2000+ employees and leading the drug development and launch activities for biologics pipeline. She is well recognized by the biomedical industry for her leadership and has received the Most Influential Women in Business Award in 2018 by San Francisco Business Times. Before Bayer, Dr. Chou held the roles of Vice President of Pharmaceutical Operations at Pfizer, Inc. and Vice President of R&D and Manufacturing at Tanvex Biopharma. Throughout Dr. Chou’s career, she has achieved significant milestones in biologics development and multiple filings of BLAs, NDAs, and INDs of novel products and is broadly recognized for her work at Genentech, Pfizer (Wyeth) and Abbvie. Currently, Dr. Chou also serves as the Board of Directors of Akero Therapeutics, Inc. and California Institute of Regenerative Medicines and Advisory Board members of UC, Berkeley Engineering School and Silicon Valley Women in Engineering. Before joining the industry, Dr. Chou was a research faculty at Harvard University Medical School and she obtained her Ph.D. from Yale University.